Price To Earnings Ratio 17.37 | Sector PE 69.70 |
PB Ratio 4.12 | Sector PB 8.89 |
EPS 77.56 | Dividend Yield 1.00 |
Today's Volume 345.625 K | 5 Day Avg. Volume 628.168 K |
PEG Ratio 0.18 | Market Cap. ₹ 25,380.00 Cr. |
Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.